A Leamington producer of medical marijuana will soon be trading on the Toronto Stock Exchange (TSX).
Aphria Inc, a Health Canada Licensed Producer of medical cannabis products, announced it will open on the market as of March 22nd.
It will trade under the symbol "APH".
With the listing on the TSX, the common shares will be delisted from the TSX Venture Exchange.
Aphria CEO Vic Neufeld says the listing on the TSX represents a major milestone in our strategic growth plan, helps to increase trading liquidity, access a growing investor base interested in the cannabis industry and raise capital for further investments.